| 產品名稱 | NCI-H1882 [H1882] |
|---|---|
| 商品貨號 | B165294 |
| Organism | Homo sapiens, human |
| Tissue | lung; Derived from metastatic site: bone marrow |
| Product Format | frozen |
| Morphology | epithelial |
| Culture Properties | adherent |
| Biosafety Level | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease | stage E,carcinoma; small cell lung cancer |
| Age | 59 years |
| Gender | male |
| Ethnicity | Caucasian |
| Applications | The line was established in April 1988. |
| Images |  |
| Derivation | The line was established in April 1988. |
| Clinical Data | The patient was a smoker. male Caucasian 59 years |
| Comments | The line was established in April 1988. The patient was a smoker. 40 pack years. |
| Complete Growth Medium | HITES medium supplemented with 5% fetal bovine serum
|
| Subculturing | Protocol: Volumes used in this protocol are for 75 sq cm flasks; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes.
Subcultivation ratio: A subcultivation ratio of 1:2 to 1:6 twice weekly is recommended. Medium renewal: Every 2 to 3 days |
| Cryopreservation | RPMI 1640, 85% ; FBS, 10%; DMSO, 5% |
| Culture Conditions | Temperature: 37.0°C |
| STR Profile | Amelogenin: X,Y CSF1PO: 11 D13S317: 12 D16S539: 12 D5S818: 11 D7S820: 10,12 THO1: 6 TPOX: 8,9 vWA: 17 |
| Name of Depositor | AF Gazdar, JD Minna |
| Deposited As | Homo sapiens |
| Year of Origin | 1988 |
| References | NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996. |
| 梅經理 | 17280875617 | 1438578920 |
| 胡經理 | 13345964880 | 2438244627 |
| 周經理 | 17757487661 | 1296385441 |
| 于經理 | 18067160830 | 2088210172 |
| 沈經理 | 19548299266 | 2662369050 |
| 李經理 | 13626845108 | 972239479 |
